Monographie - Alprostadil

Son güncelleme :
27/11/2024

Alprostadil

Kimyasal yapı

Ticari isim

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Alfaprostin	Mısır
Alistint	Peru
Alpros	Türkiye
Alprostadil	Almanya, Amerika Birleşik Devletleri, Arjantin, Ekvador, İspanya, Kanada, Malezya, Peru, Romanya, Şili, Türkiye
Alprostapint	Arjantin, Avusturya, Ekvador, Kolombiya, Macaristan, Peru
Alprostar	İtalya
Aplicav	Brezilya
Cardiobon	Arjantin, Peru
Caverject	Amerika Birleşik Devletleri, Avusturya, Belçika, Brezilya, Büyük Britanya, Danimarka, Fransa, Güney Afrika Cumhuriyeti, İspanya, İsveç, İsviçre, İtalya, Kanada, Norveç, Polonya, Portekiz, Slovenya, Türkiye
Edex	Fransa
Liple	Japonya
Minprog	Almanya, Avusturya
Ostapint	Meksika, Peru
Palux	Japonya
Pridax	Almanya, Avusturya, İspanya, Romanya
Prolisina VR	Arjantin
Prostandin	Japonya
Prostavasin	Almanya, Avusturya, İran, İtalya, Lüksemburg, Macaristan, Mısır, Polonya
Prostin VR	Amerika Birleşik Devletleri, Avustralya, Belçika, Büyük Britanya, Danimarka, Finlandiya, Hollanda, İran, İsviçre, İtalya, Kanada, Lüksemburg, Macaristan, Malezya, Norveç, Polonya, Portekiz, Suudi Arabistan, Venezuela, Yunanistan
Prostine VR	Fransa
Vasaprostan	Romanya

Kaynaklar : Alprostadil

	tip	yayın
1072	Dergi	Saltsmann CL, Tom CM, Mitchell A, Fan JH, Gailey RA. Compatibility of levofloxacin with 34 medications during simulated Y-site administration. Am J Health-Syst Pharm 1999 ; 56: 1458-1459.
1899	Dergi	Trissel LA, Zhang Y. Long-term stability of Trimix : a three drug injection used to treat rectile dysfunction. Int J Pharm Compound 2004 ; 8, 3: 231-235.
2003	Dergi	Paul M, Razzouq N, Tixier G, Astier A. Stability of prostaglandin E1 (PGE1) in aqueous solutions. EJHP Science 2005 ; 2: 31-36.
2090	Dergi	Pere H, Chasse V, Forest JM, Hildgen P. Compatibility of injectable pantoprazole in Y-site administration. Pharmactuel 2004 ; 37: 193-196.
2150	Dergi	Soli M, Bertaccini A, carparelli F, Gotti R, Cavrini V, Andrisano V, Martorana G. Vasoactive cocktails for erectile dysfunction: chemical stability of PGE1, papaverine and phentolamine. J Urology 1998 ; 160; 2: 551-555.
2151	Dergi	Gatti R, Gotti R, Cavrini V, Soli M, Bertaccini A, Carparelli F. Stability study of prostaglandin E1 (PGE1) in physiological solutions by liquid chromatography (HPLC). Int J Pharm 1995 ; 115: 113-117.
3201	Dergi	Dice JE. Physical compatibility of alprostadil with commonly used IV solutions and medications in the neonatal intensive care unit. J Pediatr Pharmacol Ther 2006 ; 11:233?6.
3448	Dergi	Vieillard V, Eychenne N, Astier A, Yiou R, Deffaux C, Paul M. Physicochemical stability study of a new Trimix formulation for treatment of erectile dysfunction. Ann Pharm Fr 2013 ; 71, 5: 358-363.
3761	Kitap	Chavan E. Etude de la stabilité de solutions de prostaglandine E1 à 48 et 72 heures en vue d'une administration parentérale en continu à des patients de néonatalogie. Master en pharmacie - University of Geneva 2014
3961	Dergi	McCluskey S.V,Kirkham K,Munson J.M. Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers. Int J Pharm Compound 2017 ; 21, 2: 150-153.
4069	Dergi	Palmero D, Chavan E, Berger-Gryllaki M, Tolsa J-F, Di Paolo E, Pannatier A, Henry H, Sadeghipour F. Stability of prostaglandin E1 solutions stored in polypropylene syringes for continuous intravenous administration to newborns. EJHP 2018 ; 25, e2
4389	Dergi	Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G. Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine. Pharmactuel 2019 ;52,4:206-213
4491	Dergi	De Basagoiti A, Katsumiti A, Abascal S, Bustinza A, López-Giménez L.R, Pilar P, De Miguel M, Campino A. Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units. Eur J Pedia 2020
4507	Dergi	Ross E, Salinas A, Petty K, Her C, Carpenter J. Compatibility of medications with intravenous lipid emulsions: Effects of simulated Y-site mixing. Am J Health-Syst Pharm 2020 ;77,23:1980-1985
4543	Dergi	Senarathna G, Strunk T, Petrovski M, Batty K. Physical compatibility of pentoxifylline and intravenous medications. Archives of Disease in Childhood 2018 ;104:292–295.
4570	Dergi	Greenhill K, Hornsby E, Gorman G. Investigations of Physical Compatibilities of Commonly Used Intravenous Medications with and without Parenteral Nutrition in Pediatric Cardiovascular Intensive Care Unit Patients. Pharmaceuticals 2019
4651	Dergi	De Basagoiti A, Katsumiti A, Abascal S, Bustinza A, López-Giménez L.R, Pascual P, De Miguel M, Campino A. Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units. Eur J Pedia 2021 ;180,1169–1176.
4837	Dergi	De Silva, D.T.N Petrovski M, Strunk T, Mukadam N, Page‑Sharp N, Moore B.R, Batty K.T. Physicochemical compatibility of caffeine citrate and caffeine base injections with parenteral medications used in neonatal intensive care settings. Eur J Clin Pharmacol 2024 ; 80:1079–1087.

Mentions Légales